Today Bubs started as a test subject in the Predicted Low Glucose Suspend algorithm for Tandem. (Official name: “Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes.”) Each participant (I think they said there would be ninety?) spends three weeks on a Tandem X2 pump with the experimental PLGS software, and three weeks on a regular X2.
Other than having to drive halfway across the widest state in our nation to get to Yale, for us there is no downside. This is a super-cool next version of the pump we already use. You know what else is super-cool? The people running this study at Yale. They are really nice people. Going over the consent form, one person inquired: Do you have any questions? Is there anything about this study that makes you uncomfortable?
I was seated across from a tippy pile of binders with a stuffed animal base, and I mentioned this made me uncomfortable.
No one was harmed by falling binders and Bubs started on the PLGS pump this afternoon. I declare it a success. I shall sleep well tonight. I already trust it. Give me. Let me buy. Want that. Good. Yes.
This is Tandem’s timeline for the new software release.